Global Recombinant Human Serum Albumin Market Professional Survey Report 2023
The global Recombinant Human Serum Albumin market was valued at US$ 69.55 million in 2021, will reach US$ 114.1 million by the end of 2028, growing at a CAGR of 7.28% during 2022-2028.
This report focuses on Recombinant Human Serum Albumin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Serum Albumin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Serum Albumin in North America, Europe, China, India, etc.
For the manufacturers covered, this report analyzes the Recombinant Human Serum Albumin manufacturing sites, capacity, production, ex-factory price, revenue and market share for each company.
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
By Region
North America
Europe
China
India
Japan
Southeast Asia
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook